Early Detection of Complications During Immunotherapy for Haematological Malignancy
NCT:NCT06377059 · RECRUITING
廣告
NCT IDNCT06377059
狀態RECRUITING
開始日期2024-12-02
完成時間2027-07-01
SponsorRigshospitalet, Denmark (OTHER)
First posted
Last updated
簡要摘要
Aims * To identify patients that should remain admitted in hospital for more intense surveillance because of high risk for development of clinical complications * Expand the understanding of the interactions between physiology and immunology for the design of future projects and general knowledge Hypothesis Development of a risk model based on a combination of physiological and immunological parameters can contribute to early detection of patients at risk for clinical complications after anti-cancer treatment.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。